Label: LACTULOSE solution

  • NDC Code(s): 0527-5120-68, 0527-5120-70, 0527-5120-78
  • Packager: Lannett Company, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated January 21, 2020

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION
    I5120C0918 - R09/18 - Rx ONLY
  • DESCRIPTION
    Lactulose is a synthetic disaccharide in solution form for oral administration. Each 15 mL of Lactulose Solution contains: 10 g lactulose (and less than 1.6 g galactose, less than 1.2 g lactose ...
  • CLINICAL PHARMACOLOGY
    Lactulose is poorly absorbed from the gastrointestinal tract, and no enzyme capable of hydrolysis of this disaccharide is present in human gastrointestinal tissue. As a result, oral doses of ...
  • INDICATIONS AND USAGE
    For the treatment of constipation. In patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which ...
  • CONTRAINDICATIONS
    Since lactulose solution contains galactose (less than 1.6 g/15 mL), it is contraindicated in patients who require a low galactose diet.
  • WARNINGS
    A theoretical hazard may exist for patients being treated with lactulose solution who may be required to undergo electrocautery procedures during proctoscopy or colonoscopy.  Accumulation of H2 ...
  • PRECAUTIONS
    General: Since lactulose solution contains galactose (less than1.6 g/15 mL) and lactose (less than 1.2 g/15 mL), it should be used with caution in diabetics. Information for Patients: In ...
  • ADVERSE REACTIONS
    Precise frequency data are not available. Initial dosing may produce flatulence and intestinal cramps, which are usually transient. Excessive dosage can lead to diarrhea with potential ...
  • OVERDOSAGE
    Signs and Symptoms - There have been no reports of accidental overdosage. In the event of overdosage, it is expected that diarrhea and abdominal cramps would be the major symptoms. Medication ...
  • DOSAGE AND ADMINISTRATION
    The usual dose is 1 to 2 tablespoonfuls (15 to 30 mL, containing 10 g to 20 g of lactulose) daily. The dose may be increased to 60 mL daily if necessary. Twenty-four to 48 hours may be required to ...
  • HOW SUPPLIED
    NDC 0527-5120-68: 8 fl oz (237 mL) bottle - NDC 0527-5120-70: 16 fl oz (473 mL) bottle - NDC 0527-5120-78: 32 fl oz (946 mL) bottle - Lactulose solution contains lactulose 667 mg/mL (10 g/15 ...
  • SPL UNCLASSIFIED SECTION
    Distributed by: Lannett Company, Inc. Philadelphia, PA 19154 - L6868 - R09/18
  • PRINCIPAL DISPLAY PANEL - 473 mL Bottle Label
    NDC 0527-5120-70 - Lactulose Solution USP - 10 g/15 mL - Each 15 mL contains: 10 g lactulose (and less than - 1.6 g galactose, less than 1.2 g lactose, and 1.2 g or - less of ...
  • INGREDIENTS AND APPEARANCE
    Product Information